Purchase Order 75N93020P00776
Award Date 6/22/20
Potential Completion Date 9/25/20
Potential Value $338K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc. for a NextSeq 2000 sequencing system to support COVID-19 research. The $341,700.00 award did not have a set-aside designation. Illumina is a manufacturer of genomic sequencing instruments and reagents that has received prior federal contract awards from agencies such as the National Institutes of Health,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $289,275 firm-fixed price purchase order to Illumina, Inc. of San Diego, California. The contract is for one NEXTSEQ 2000 SEQUENCING SYSTEM to support ongoing COVID-19 and infectious disease research. Delivery is required by January 31, 2023 in Bethesda, Maryland per the original solicitation seeking offers for the Illumina NextSeq-2000 sequencing system and...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Illumina, Inc. for $341,700 on August 17, 2020 to procure a NextSeq 2000 sequencing system in support of COVID-19 research. The order carries firm fixed-price pricing with no set-aside. Performance occurs in San Diego, California, with an ultimate completion date of December 31, 2020. The procurement was designated under the Coronavirus COVID-19 National Interest Action Code.</p>
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc. for a NextSeq 2000 Sequencing System or equal, valued at $239,700.00. The requirement was issued through a commercial items solicitation using Simplified Acquisition Procedures, with no set-aside designation. The sequencing system is intended to support the increased workload at the Center for Human Immunology,...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $340,025 firm fixed price purchase order to Illumina, Inc. to deliver one NextSEQ2000 genome sequencer to the Laboratory of Parasitic Diseases. The sequencer will support the laboratory's SARS-CoV-2 and other research efforts. As the prime contractor, Illumina will furnish the requested high-throughput sequencer from its San Diego, California location by the end date of October 25, 2021 to meet...
- The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions, for the NextSeq 1000 Sequencing System. The $213,150.00 contract supports NIAID's Vaccine Immunology Program's research into monoclonal antibodies and vaccines for infectious diseases such as HIV, influenza, Ebola, and SARS-CoV-2....
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a delivery order contract to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract is for the purchase of NextSeq 1000/2000 and MiSeq reagent kits, valued at $109,656.60. The order supports the agency's Coronavirus COVID-19 response efforts. The contract is awarded on a firm fixed-price basis with no set-aside...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $207,415 firm fixed price purchase order to Illumina, Inc. of San Diego, California. Under the terms of the contract, Illumina will provide one NEXTSEQ 2000 sequencing system to support NIH's research efforts in the areas of allergy and infectious disease. Place of performance is Illumina's facilities in San Diego. The period of performance is from...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $193,260.38 firm fixed price delivery order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The award is for the provision of Illumina NextSeq, iSeq, and MiSeq sequencing kits to support COVID-19 research. Illumina has previously received prime federal contracts and subcontracts from agencies such as the National Institutes of...
- Illumina, Inc. was awarded a $898,275 firm fixed-price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide an Illumina NovaSeq 6000 sequencing system. The contract is in support of the Department of Health and Human Services' efforts responding to the Coronavirus Disease 2019 pandemic and will run from September 2021 through September 2022. Performance will take place in San Diego, California. No set-aside designation or...